Sinclair Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners. Sinclair Pharma plc is listed on the London Stock Exchange AIM market
Type
Public
HQ
London, GB
Founded
1971
Size (employees)
173 (est)-4%
Sinclair Pharma was founded in 1971 and is headquartered in London, GB
Report incorrect company information

Sinclair Pharma Office Locations

Sinclair Pharma has offices in Frankfurt am Main, London, Paris, San Fernando de Henares and in 1 other location
London, GB (HQ)
Whitfield Court 26-28 Whitfield St
Cheshire West and Chester, GB
Office Village
Paris, FR
46 Rue de la Bienfaisance
Frankfurt am Main, DE
1 Westhafenpl.
San Fernando de Henares, ES
Parque Empresarial de San Fernando. Ed Dublin planta 2
Show all (5)
Report incorrect company information

Sinclair Pharma Financials and Metrics

Sinclair Pharma Financials

Sinclair Pharma's revenue was reported to be £45.49 m in FY, 2016
GBP

Revenue (FY, 2016)

45.5 m

Gross profit (FY, 2016)

31.8 m

Gross profit margin (FY, 2016), %

69.9%

Net income (FY, 2016)

(33.4 m)

EBITDA (FY, 2016)

(9.1 m)

EBIT (FY, 2016)

(18.2 m)

Market capitalization (31-Oct-2017)

147.1 m

Closing share price (31-Oct-2017)

0.3

Cash (31-Dec-2016)

16.8 m
Sinclair Pharma's current market capitalization is £147.1 m.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

23.2 m30.3 m30.4 m27.6 m32.9 m51.4 m55.4 m63.6 m27.8 m45.5 m

Revenue growth, %

15%19%

Cost of goods sold

8.1 m10.8 m9.7 m10.4 m14.1 m20.8 m21.7 m27.8 m9.3 m13.7 m

Gross profit

15.1 m19.4 m20.7 m17.2 m18.8 m30.6 m33.6 m35.8 m18.6 m31.8 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.8 m1.1 m88 k2.1 m5.1 m4 m5.1 m17.5 m12.7 m16.8 m

Accounts Receivable

6.6 m12 m7.5 m8.1 m12.6 m14.7 m16.9 m25.2 m23.9 m11.2 m

Inventories

2.2 m3.4 m3.8 m4.8 m9.6 m5.8 m4.8 m7.6 m7.6 m3.8 m

Current Assets

12.8 m20.5 m13.7 m16.9 m33.4 m27.1 m29.8 m55.8 m47.9 m33.9 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(4.2 m)3.3 m(3.6 m)(17.6 m)(11.7 m)(5.1 m)(15.8 m)(4.1 m)(23.4 m)(33.4 m)

Cash From Operating Activities

1.6 m3.7 m(470 k)(6.7 m)(9.8 m)913 k969 k(6.8 m)4.3 m(19.3 m)

Cash From Financing Activities

307 k4.6 m2 m28 m2.9 m8.7 m7.4 m63.6 m(982 k)(56.7 m)

Net Change in Cash

1.8 m3.3 m(1.3 m)3.4 m2.9 m(757 k)1 m12.7 m(5.1 m)3.3 m
GBPY, 2016

Financial Leverage

1.8 x
Show all financial metrics

Sinclair Pharma Operating Metrics

Sinclair Pharma's Training Provided, no. of people was reported to be 300 in FY, 2016.
FY, 2016

Training Provided, no. of people

300
Show all operating metrics
Report incorrect company information